当前位置: 首页 > 期刊 > 《中国现代医生》 > 2016年第34期 > 正文
编号:13071043
HER—4在结直肠癌中的表达及其临床意义(4)
http://www.100md.com 2016年12月5日 中国现代医生2016年第34期
     [17] Zhao WY,Zhuang C,Xu J,et al. HER4 is a novel prognostic biomarker in gastrointestinal stromal tumor specifically originated from stomach[J]. Am J Cancer Res,2014, 4(6):838-849.

    [18] Kountourakis P,Pavlakis K,Psyrri A,et al. Prognostic significance of HER3 and HER4 protein expression in colorectal adenocarcinomas[J]. BMC Cancer,2006,6:46.

    [19] Lee JC,Wang ST,Chow NH,et al. Investigation of the prognostic value of coexpressed erbB family members for the survival of colorectal cancer patients after curative surgery[J]. Eur J Cancer,2002,38(8):1065-1071.

    [20] Baiocchi G,Lopes A,Coudry RA,et al. ErbB family immunohistochemical expression in colorectal cancer patients with higher risk of recurrence after radical surgery[J].Int J Colorectal Dis,2009,24(9):1059-1068.

    [21] He XX,Ding L,Lin Y,et al. Protein expression of HER2, 3,4 in gastric cancer:Correlation with clinical features and survival[J]. J Clin Pathol,2015,68(5):374-380.

    [22] Sasaki H,Okuda K,Kawano O,et al. ErbB4 expression and mutation in Japanese patients with lung cancer[J]. Clin Lung Cancer,2007,8(7):429-433.

    [23] Hollmen M,Maatta JA,Bald L,et al. Suppression of breast cancer cell growth by a monoclonal antibody targeting cleavable ErbB4 isoforms[J]. Oncogene,2009,28(10):1309-1319.

    (收稿日期:2016-08-02) (刘传渊 夏来阳 刘金秀 王建)
上一页1 2 3 4